Your browser doesn't support javascript.
loading
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
Figlioli, Gisella; Billaud, Amandine; Wang, Qin; Bolla, Manjeet K; Dennis, Joe; Lush, Michael; Kvist, Anders; Adank, Muriel A; Ahearn, Thomas U; Antonenkova, Natalia N; Auvinen, Päivi; Behrens, Sabine; Bermisheva, Marina; Bogdanova, Natalia V; Bojesen, Stig E; Bonanni, Bernardo; Brüning, Thomas; Camp, Nicola J; Campbell, Archie; Castelao, Jose E; Cessna, Melissa H; Czene, Kamila; Devilee, Peter; Dörk, Thilo; Eriksson, Mikael; Fasching, Peter A; Flyger, Henrik; Gabrielson, Marike; Gago-Dominguez, Manuela; García-Closas, Montserrat; Glendon, Gord; Gómez Garcia, Encarna B; González-Neira, Anna; Grassmann, Felix; Guénel, Pascal; Hahnen, Eric; Hamann, Ute; Hillemanns, Peter; Hooning, Maartje J; Hoppe, Reiner; Howell, Anthony; Humphreys, Keith; Jakubowska, Anna; Khusnutdinova, Elza K; Kristensen, Vessela N; Lindblom, Annika; Loizidou, Maria A; Lubinski, Jan; Mannermaa, Arto; Maurer, Tabea.
Afiliação
  • Figlioli G; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
  • Billaud A; Genome Diagnostics Program, IFOM ETS-The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Kvist A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, 22185 Lund, Sweden.
  • Adank MA; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Family Cancer Clinic, 1066 CX Amsterdam, The Netherlands.
  • Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
  • Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.
  • Auvinen P; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.
  • Behrens S; Institute of Clinical Medicine, Oncology, University of Eastern Finland, 70210 Kuopio, Finland.
  • Bermisheva M; Department of Oncology, Cancer Center, Kuopio University Hospital, 70210 Kuopio, Finland.
  • Bogdanova NV; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Bojesen SE; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, 450054 Ufa, Russia.
  • Bonanni B; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.
  • Brüning T; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.
  • Camp NJ; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
  • Campbell A; Copenhagen General Population Study, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
  • Castelao JE; Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
  • Cessna MH; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Nbcs Collaborators; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Czene K; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), 44789 Bochum, Germany.
  • Devilee P; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
  • Dörk T; Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh EH4 2XU, UK.
  • Eriksson M; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH16 4UX, UK.
  • Fasching PA; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, 36312 Vigo, Spain.
  • Flyger H; Intermountain Health, Salt Lake City, UT 84111, USA.
  • Gabrielson M; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, 0379 Oslo, Norway.
  • Gago-Dominguez M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.
  • García-Closas M; Department of Research, Vestre Viken Hospital, 3019 Drammen, Norway.
  • Glendon G; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 2371 Nicosia, Cyprus.
  • Gómez Garcia EB; Section for Breast- and Endocrine Surgery, Department of Cancer, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Ullevål, 0450 Oslo, Norway.
  • González-Neira A; Department of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.
  • Grassmann F; Department of Pathology, Akershus University Hospital, 1478 Lørenskog, Norway.
  • Guénel P; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
  • Hahnen E; Department of Oncology, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Radiumhospitalet, 0379 Oslo, Norway.
  • Hamann U; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, 0379 Oslo, Norway.
  • Hillemanns P; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway.
  • Hooning MJ; Oslo Breast Cancer Research Consortium, Oslo University Hospital, 0379 Oslo, Norway.
  • Hoppe R; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Howell A; Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Humphreys K; Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • kConFab Investigators; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
  • Jakubowska A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Khusnutdinova EK; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
  • Kristensen VN; Department of Breast Surgery, Copenhagen University Hospital, Herlev and Gentofte Hospital, 2730 Herlev, Denmark.
  • Lindblom A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Loizidou MA; Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS) Foundation, IDIS Cancer Genetics and Epidemiology Group, Genomic Medicine Group, Complejo Hospitalario Universitario de Santiago, SERGAS, 15706 Santiago de Compostela, Spain.
  • Lubinski J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD 20892, USA.
Cancers (Basel) ; 15(13)2023 Jun 23.
Article em En | MEDLINE | ID: mdl-37444426

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália